Jeffrey Winger
Family · St George, UTNPI 1154686467
Payments from drug & device makers
Across 246 payments — averaging $15.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$990
- Amgen$518
- Pfizer$312
- Lilly USA, LLC$302
- Boehringer Ingelheim$230
- AstraZeneca$208
- plus $1K from 30 others
What the payments were for
- Food & beverage$3,912100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 64 | $990 |
| Amgen(2 entities) | 31 | $518 |
| Pfizer | 17 | $312 |
| Lilly USA, LLC | 32 | $302 |
| Boehringer Ingelheim | 14 | $230 |
| AstraZeneca | 12 | $208 |
| Boston Scientific | 8 | $195 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $129 |
| Johnson & Johnson | 6 | $116 |
| GSK | 7 | $108 |
| Novo Nordisk | 5 | $73 |
| Sumitomo Pharma America, Inc. | 3 | $66 |
| Merck | 4 | $64 |
| Phathom Pharmaceuticals, Inc. | 3 | $60 |
| Sanofi-aventis U.S. LLC | 2 | $52 |
| Organon | 3 | $48 |
| Exact Sciences | 3 | $45 |
| Lucid Diagnostics Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Sanofi Pasteur Inc. | 1 | $33 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $30 |
| Almatica Pharma LLC | 2 | $27 |
| Inogen, Inc. | 1 | $22 |
| Grifols USA, LLC | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| RGH Enterprises LLC | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Harmony Biosciences LLC | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $13 |
| Abbott | 1 | $13 |
| Optinose US, Inc. | 1 | $13 |
| Nevro Corp. | 1 | $13 |
| Medtronic | 1 | $12 |
How this compares
$3,912 in reported general payments places this provider in the 90th percentile of 1,460 family providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 103 | $118,678 |
| OzempicSemaglutide | 89 | $98,689 |
| TrulicityDulaglutide | 66 | $71,239 |
| JardianceEmpagliflozin | 55 | $66,834 |
| MounjaroTirzepatide | 44 | $48,053 |
| XareltoRivaroxaban | 26 | $33,162 |
| MyrbetriqMirabegron | 34 | $26,438 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $18,662 |
| VraylarCariprazine Hcl | 13 | $17,616 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $16,324 |
| Omeprazole | 421 | $6,552 |
| Tamsulosin Hcl | 300 | $5,637 |
| Duloxetine Hcl | 168 | $5,372 |
| Atorvastatin Calcium | 583 | $5,355 |
| Levothyroxine Sodium | 551 | $5,198 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Premarin | $312 | $123,868120 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $302 | $119,292110 claims |
| Novo NordiskOzempic | $73 | $98,68989 claims |
| Boehringer IngelheimJardiance | $230 | $66,83455 claims |
| Johnson & JohnsonXarelto | $116 | $33,16226 claims |
| AbbVieVraylar, Synthroid | $990 | $20,76044 claims |
| GSKTrelegy Ellipta | $108 | $18,66227 claims |
| MerckJanumet | $64 | $16,32412 claims |
| AstraZenecaSymbicort | $208 | $3,49813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,460 family providers in Utah.
Other family in St George
- Allie BlazzardSt George$44K
- Kelsie MontgomerySt George$15K
- Ashlee WalkerSt George$8K
- Michelle BallardSt George$8K
- Amanda TurnerSt George$8K
- Riley WorthSandy$1.1M
- Katrina BawdenSalt Lake City$446K
- Cortnee RomanSalt Lake City$374K
- Jared ThorleySalt Lake City$368K
- Stephanie GodfreyLindon$358K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.